Know Cancer

or
forgot password
  • cancer clinical trials in bowling green, OH

  • Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Esophageal Cancer, Gastric Cancer
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Endometrial Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Recurrent Mantle Cell Lymphoma
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Brain and Central Nervous System Tumors
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Brain and Central Nervous System Tumors
    Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Carcinoma of Unknown Primary
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Brain and Central Nervous System Tumors
    Study of Tissue and Blood Samples From Patients With High-Grade Glioma
    Wood County Oncology Center
    Bowling Green, Ohio 43402
    Brain and Central Nervous System Tumors
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Toledo Clinic Cancer Centers-Bowling Green
    Bowling Green, Ohio 43402
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer